US Patent Issued to UNIVERSITE DE TOURS, UNIVERSITE DE PICARDIE JULES VERNE, CENTRE HOSPITALIER UNIVERSITAIRE AMIENS-PICARDIE on July 22 for "Antibody targeting the VP-1 protein, fragments thereof, and uses of same for detecting infection with the BK polyomavirus" (French Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,721, issued on July 22, was assigned to UNIVERSITE DE TOURS (Tours, France), UNIVERSITE DE PICARDIE JULES VERNE (Amiens, France) and CENTRE HOSPITALIER UNIVERSITAIRE AMIENS-PICARDIE (Amiens, France).

"Antibody targeting the VP-1 protein, fragments thereof, and uses of same for detecting infection with the BK polyomavirus" was invented by Antoine Touze (Montbazon, France), Pauline Gaboriaud (Esvres-sur-Indre, France) and Etienne Brochot (Amiens, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a new monoclonal antibody targeting the VP-1 protein of the capsid of the BK polyomavirus, fragments thereof, and uses of same fo...